Osteoarthritis Market is expected to showcase exceptional Growth by 2032 – Estimates DelveInsight | Key Companies- Novartis, Peptinov, 4P Pharma, Sorrento, Eupraxia, Biosplice, Ampio, Bone Therapeutics, & Others

DelveInsight's "Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Osteoarthritis, historical and forecasted epidemiology as well as the Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

Some facts of Osteoarthritis Market Report:

·        According to the EULAR Study Group (2015), it was estimated that OA affects about 40 million people in Europe. It was relatively infrequent in people under the age of 40 years but increased definitely with age. Under the age of 45 women were less affected than males which reverse above the age of 45.

·        Osteoarthritis (OA) is the 4th leading cause of disability across the world and is thought to be the most prevalent of all musculoskeletal pathologies, affecting an estimated 10% of the world’s population over the age of 60.

·        According to Osteoarthritis Action Alliance, while there are estimated to be more than 100 types of arthritis, OA is the most common form of arthritis, affecting 32.5 million US adults. 43% of people with OA are 65 or older and 88% of people with OA are 45 or older. 62% of individuals with OA are women. Among people younger than 45, OA is more common among men; above age 45, OA is more common among women.

·        Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment can act as a market barrier.

Get More Detailed Insights into the Osteoarthritis Market Report: https://www.delveinsight.com/sample-request/osteoarthritis-market

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

Osteoarthritis Pipeline therapies and Companies:

·        DK 004: Jiangsu Carephar Pharmaceutical

·        4P-004: 4P Pharma

·        LNA043: Novartis

·        LRX712: Novartis

·        X 0002: Techfields Pharma

·        DMI 9523: Ampio Pharmaceuticals

·        PPV-06: Peptinov

·        And Others.

Get More Detailed Insights into the Emerging Therapies & Key Companies: https://www.delveinsight.com/sample-request/osteoarthritis-market

The Osteoarthritis therapeutics market has a promising outlook with the emerging therapies, consisting of several Phase III and Phase II assets.

Osteoarthritis Market Drivers

·        Growing geriatric population and hence the rising prevalence of osteoarthritis

·        Favorable government policies to support the development of new therapies for the Osteoarthritis, and Others

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

·        Chronic Refractory Cough Market

·        Cardiopulmonary Bypass Equipment Market

·        Cardiac Biomarkers Testing Devices Market

·        Epithelial Ovarian Cancer Market

·        Surgical Site Infection Ssi Market

·        Keloid Market

·        Synchronous Endometrial And Ovarian Carcinoma Market

·        Autosomal Recessive Congenital Ichthyosis Market

·        Rituximab Biosimilars Insight

·        Adamantinoma Market

·        Hpv-induced Cancers Market

·        Pain Management Devices Market

·        Continuous Renal Replacement Therapy Machines Market

·        Parkinsons Disease Related Dementia Market

·        22q11.2 Deletion Syndrome Market

·        Pediatric Growth Hormone Deficiency Pghd Market

·        Brain Aneurysm Stents Market

·        Dermal Erythema Market

·        Pelvic Inflammatory Disease Market

·        Polypoidal Choroidal Vasculopathy Market